COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 1806: Articles 18051-18060  | Next

Socioeconomic Disparities and COVID-19 Vaccination Acceptance: Experience from Israel
Caspi, G., Dayan, A., Eshal, Y., Taub, S. L., Twig, G., Shalit, U., Lewis, Y., Shina, A., Caspi, O.
10.1101/2021.01.28.21250716 — Posted: 2021-02-01
Discrimination of SARS-Cov 2 and arboviruses (DENV, ZIKV and CHIKV) clinical features using machine learning techniques: a fast and inexpensive clinical screening for countries simultaneously affected by both diseases
Santos Castro, J. D.
10.1101/2021.01.28.21250714 — Posted: 2021-02-01
Hot days and Covid19 - unusual heat stress for nursing professions in Germany
Jegodka, Y., Lagally, L., Mertes, H., Deering, K., Schoierer, J., Buchberger, B., Bose-O'Reilly, S.
10.1101/2021.01.29.21250592 — Posted: 2021-02-01
Uncovering Survivorship Bias in Longitudinal Mental Health Surveys
Czeisler, M. E., Wiley, J. F., Czeisler, C. A., Rajaratnam, S. M. W., Howard, M. E.
10.1101/2021.01.28.21250694 — Posted: 2021-02-01 Discussion: Onsite
The mobility gap: estimating mobility levels required to control Canada's winter COVID-19 surge
Brown, K. A., Soucy, J.-P. R., Buchan, S. A., Sturrock, S. L., Berry, I., Stall, N. M., Juni, P., Ghasemi, A., Gibb, N., MacFadden, D. R., Daneman, N.
10.1101/2021.01.28.21250622 — Posted: 2021-02-01
Prediction Models for Severe Manifestations and Mortality due to COVID-19: A Rapid Systematic Review
Miller, J., Tada, M., Goto, M., Mohr, N. M., Lee, S.
10.1101/2021.01.28.21250718 — Posted: 2021-02-01
Surveillance-to-Diagnostic Testing Program for Asymptomatic SARS-CoV-2 Infections on a Large, Urban Campus - Georgia Institute of Technology, Fall 2020
Gibson, G. C., Weitz, J. S., Shannon, M. P., Holton, B., Bryksin, A., Liu, B., Bramblett, S., Williamson, J., Farrell, M., Ortiz, A., Abdallah, C. T., Garcia, A.
10.1101/2021.01.28.21250700 — Posted: 2021-01-31 Discussion: Onsite
Racial and Ethnic Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: An Analysis of 45 States and the District of Columbia
Xu, J. J., Chen, J. T., Belin, T. R., Brookmeyer, R. S., Suchard, M. A., Ramirez, C. M.
10.1101/2021.01.28.21249411 — Posted: 2021-01-31
A control framework to optimize public health policies in the course of the COVID-19 pandemic
Pataro, I. M. L., Oliveira, J. F., Morato, M. M., Amad, A. A. S., Ramos, P. I. P., Pereira, F. A. C., Silva, M. S., Jorge, D. C. P., Andrade, R. F. S., Barreto, M. L., Americano da Costa, M.
10.1101/2021.01.28.21250692 — Posted: 2021-01-31
Title: Health and Healthcare Variables Associated with Italy's Excess Mortality during the First Wave of the COVID-19 pandemic: An Ecological Study.
Buja, A., Paganini, M., Fusinato, R., Cocchio, S., Scioni, M., Rebba, V., Baldo, V., Boccuzzo, G.
10.1101/2021.01.28.21250669 — Posted: 2021-01-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).